Search Results - "Sandy Pillay"
-
1
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group
Published in PloS one (13-02-2023)“…The WHO recommended 1200mg/day of fluconazole (FCZ) in the induction phase of cryptococcal meningitis (CM) in HIV prior to 2018 in regions where amphotericin-B…”
Get full text
Journal Article -
2
The Medical Education Partnership Initiative (MEPI): Innovations and Lessons for Health Professions Training and Research in Africa
Published in Annals of global health (30-04-2018)“…MEPI was a $130 million competitively awarded grant by President's Emergency Plan for AIDS Relief (PEPFAR) and National Institutes of Health (NIH) to 13…”
Get full text
Journal Article -
3
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study
Published in BMC medicine (24-09-2018)“…Various individual biomarkers of inflammation and micronutrient status, often correlated with each other, are associated with adverse treatment outcomes in…”
Get full text
Journal Article -
4
Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation
Published in Clinical infectious diseases (01-07-2015)“…Anemia is a known risk factor for clinical failure following antiretroviral therapy (ART). Notably, anemia and inflammation are interrelated, and recent…”
Get full text
Journal Article -
5
Medical Education Partnership Initiative gives birth to AFREhealth
Published in The Lancet global health (01-10-2017)Get full text
Journal Article -
6
Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy
Published in Nutrients (13-11-2014)“…A case-cohort study, within a multi-country trial of antiretroviral therapy (ART) efficacy (Prospective Evaluation of Antiretrovirals in Resource Limited…”
Get full text
Journal Article -
7
Predictors of site choice and eventual learning experiences in a decentralised training programme designed to prepare medical students for careers in underserved areas in South Africa
Published in African journal of health professions education (01-05-2016)“…Background. There is a dire need for medical schools in South Africa to train medical doctors who have the capacity and willingness to work in primary…”
Get full text
Journal Article -
8
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis
Published in PloS one (13-02-2023)“…Background The WHO recommended 1200mg/day of fluconazole (FCZ) in the induction phase of cryptococcal meningitis (CM) in HIV prior to 2018 in regions where…”
Get full text
Journal Article -
9
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection
Published in Annals of internal medicine (01-03-2023)“…Although symptom and viral rebound have been reported after nirmatrelvir-ritonavir treatment, the trajectories of symptoms and viral load during the natural…”
Get full text
Journal Article -
10
Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation
Published in Journal of acquired immune deficiency syndromes (1999) (01-10-2016)“…BACKGROUND:Women progress to death at the same rate as men despite lower plasma HIV RNA (viral load). We investigated sex-specific differences in immune…”
Get full text
Journal Article -
11
Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults
Published in The Journal of infectious diseases (01-07-2016)“…Background. Both wasting and obesity are associated with inflammation, but the extent to which body weight changes influence inflammation during human…”
Get full text
Journal Article -
12
Viral and symptom rebound following anti-SARS-CoV-2 monoclonal antibody therapy in a randomized placebo-controlled trial
Published in The Journal of infectious diseases (14-10-2024)“…We explored viral and symptom rebound after COVID-19 amubarvimab/romlusevimab monoclonal antibody therapy vs placebo in the randomized ACTIV-2/A5401 trial…”
Get full text
Journal Article -
13
HIV and COPD: a conspiracy of risk factors
Published in Respirology (Carlton, Vic.) (01-10-2016)“…Chronic obstructive pulmonary disease (COPD) is an under recognized complication of HIV infection. It is estimated that up to 25% of HIV infected people may…”
Get full text
Journal Article -
14
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size
Published in Clinical infectious diseases (14-11-2022)“…Abstract Background Identifying factors that determine the frequency of latently infected CD4+ T cells on antiretroviral therapy (ART) may inform strategies…”
Get full text
Journal Article -
15
Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study
Published in Journal of acquired immune deficiency syndromes (1999) (01-07-2017)“…Numerous micronutrients have immunomodulatory roles that may influence risk of tuberculosis (TB), but the association between baseline micronutrient…”
Get full text
Journal Article -
16
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial
Published in The Lancet (British edition) (19-03-2016)“…Summary Background Mortality within the first 6 months after initiating antiretroviral therapy is common in resource-limited settings and is often due to…”
Get full text
Journal Article -
17
A Strategy for Developing Future Academic Leaders for South Africa in a Resource-Constrained Environment
Published in Academic medicine (01-08-2014)“…A key challenge in addressing the shortage of health care workers in resource-constrained environments is ensuring that there is optimal academic capacity for…”
Get full text
Journal Article -
18
Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention
Published in Journal of antimicrobial chemotherapy (11-02-2021)“…Abstract Background The use of rifamycin antibiotics for TB prevention carries a risk of detrimental drug–drug interactions with concomitantly used ART…”
Get full text
Journal Article -
19
HIV Prevention Counseling Intervention Delivered During Routine Clinical Care Reduces HIV Risk Behavior in HIV-Infected South Africans Receiving Antiretroviral Therapy: The Izindlela Zokuphila/Options for Health Randomized Trial
Published in Journal of acquired immune deficiency syndromes (1999) (15-12-2014)“…CONTEXT:Sustainable interventions are needed to minimize HIV risk behavior among people living with HIV (PLWH) in South Africa on antiretroviral therapy (ART),…”
Get full text
Journal Article -
20
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings
Published in The Journal of infectious diseases (01-04-2016)“…A case-cohort analysis of human immunodeficiency virus (HIV)–infected individuals receiving antiretroviral therapy (ART) was performed within a multicountry…”
Get full text
Journal Article